TY  - GEN
N2  - This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.
DO  - 10.1007/978-3-030-70063-8
DO  - doi
AB  - This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.
T1  - Organotypic models in drug development /
AU  - Schäfer-Korting, Monika,
AU  - Stuchi Maria-Engler, Silvya,
AU  - Landsiedel, Robert,
VL  - volume 265
CN  - RM301.25
ID  - 1435404
KW  - Drug development.
KW  - Tissue engineering.
KW  - Tissue culture.
KW  - Pharmacology, Experimental.
KW  - Médicaments
KW  - Génie tissulaire.
KW  - Tissus (Histologie)
KW  - Pharmacologie expérimentale.
SN  - 9783030700638
SN  - 3030700631
SN  - 9783030700645
SN  - 303070064X
SN  - 9783030700652
SN  - 3030700658
TI  - Organotypic models in drug development /
LK  - https://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-70063-8
UR  - https://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-70063-8
ER  -